Form 4: Molina Healthcare Director Steven Orlando Acquires Shares Under Equity Incentive Plan

Sentiment:

SEC Form 4 Filing


Director Steven Orlando acquired 188 shares of Molina Healthcare common stock on July 1, 2024, as part of the company's 2019 Equity Incentive Plan.

Summary

  • On July 1, 2024, Steven Orlando, a director of Molina Healthcare, Inc., acquired 188 shares of common stock.
  • The acquisition was part of the Issuer's 2019 Equity Incentive Plan and is related to his services as a Director.
  • The shares were granted at a price of $292.16 per share, which was the closing price of Molina Healthcare's common stock on that day.
  • This grant is part of an annual equity award to each director, valued at $220,000, with $55,000 granted each quarter.
  • Following the transaction, Orlando directly owns 19,025 shares held by a trust and 1,500 shares held by his 401(k) plan.

Sentiment

Score: 7

Explanation: The document reflects a routine equity grant to a director, indicating standard corporate governance practices. It's a neutral event with a slightly positive sentiment due to the alignment of interests between management and shareholders.

Positives

  • The equity incentive plan aligns director compensation with company performance.
  • Director's acquisition of shares demonstrates confidence in the company's future.

Industry Context

Equity compensation is a common practice in the healthcare industry to align the interests of directors and shareholders.

Comparison to Industry Standards

  • Director compensation packages, including equity grants, are typical in publicly traded healthcare companies.
  • The specific value and structure of the equity awards can vary based on company size, performance, and industry benchmarks.
  • Comparing Molina Healthcare's director compensation to peers like UnitedHealth Group, Anthem, or Cigna would provide further context.

Stakeholder Impact

  • The equity grant aligns the director's interests with those of the shareholders.
  • The grant does not have a significant impact on employees, customers, suppliers, or creditors.

Key Dates

DateDescription
2011-02-16Limited Power of Attorney executed
2024-07-01Date of stock acquisition

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.